New Clinical Research Data Supports Crestor Diabetes Lawsuits

June 30, 2011

Pharmaceutical product liability lawyers at Pintas & Mullins are warning of new clinical research confirming an increased diabetes risk for users of Crestor and similar cholesterol lowering drugs. The findings show that the higher the Crestor dose, the greater the risk of developing diabetes. Crestor has also been linked to other dangerous side effects, including tissue damage and kidney failure.
The danger is widespread, because statin drugs like Crestor, Zocor, and Lipitor are among the best-selling drugs in the United States. These drugs slow down cholesterol production in the body, and are usually taken to lower the risk of heart attack, stroke, or heart disease. Unfortunately, these popular drugs are also hazardous, especially when taken in large doses.

A new study in the Bloomberg News Report confirms a link between statins and diabetes, one of the most serious health complications Crestor users experience. European researchers conducted five clinical trials involving more than 32,000 patients. All of the study participants were given statin drugs, and some were given higher doses than others. The study found that those taking higher doses were 12 percent more likely to develop potentially life-threatening diabetes.

The latest study lends additional support to earlier research published by the Lancet medical journal in 2010, which also found that Crestor and other statins increase a patient's risk for diabetes. Examining more than 90,000 patients, researchers found that Crestor users had a 9 percent increased diabetes risk compared to those taking a placebo.

Medical experts are still trying to understand the diabetes link, but animal studies suggest that statins like Crestor increase the muscle's resistance to insulin, elevating blood sugar levels. This results in type 2 diabetes, which can lead to fatal heart attacks and stroke if left untreated.

In addition to an increased risk for developing diabetes, users should also be aware of rhabdomylosis, another dangerous Crestor side effect. This devastating disease can affect a patient's entire body, depleting muscle mass and strength. It also diminishes heart tissue, resulting in serious heart conditions. These health complications led the FDA to issue a warning update for Crestor and other statin drug labels in 2005.
Patients taking Crestor or other statins that develop type 2 diabetes or suffer heart attacks may have legal recourse. Our defective drug lawyers understand that each case is unique and must be evaluated an on individual basis. For those injured while taking Crestor medication, a Crestor lawsuit can help pay for medical bills and other related expenses.

Scientific studies prove that statins like Crestor cause harmful side effects, including diabetes and major cardiovascular events. These health complications may have long-lasting consequences for patients and result in compensable injuries. Type 2 diabetes patients need to continuously monitor their chronic condition, and they face up to five times the healthcare costs that an average, healthy person would be forced to pay. Diabetes is also a leading cause of heart attack and stroke, which is ironic given that Crestor is promoted for its ability to reduce heart complications. Our experienced attorneys know that injured Crestor victims and their families do not have to suffer alone. When someone is injured by a defective prescription drug, they have the legal right to hold the drug manufacturer liable for the harm that they cause.